Volume 4, Number 1—March 1998
Perspective
Risk for Transfusion-Transmitted Infectious Diseases in Central and South America
Table 1
Coverage of screeninga of blood donors and seroprevalence rates (per 1,000) of infectious diseases, by countryb
| Country | HIV |
HBVc |
HCV |
Syphilis |
T. cruzi |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cov.d (%) | Prev.e (/103) | Cov. (%) | Prev. (/103) | Cov. (%) | Prev. (/103) | Cov. (%) | Prev. (/103) | Cov. (%) | Prev. (/103) | |
| Bolivia | 36.2 | 0.10 | 14.5 | 2.00 | 0 | ?f | 37.9 | 18.10 | 29.4 | 147.90 |
| Chile | 100 | 3.40 | 98.7 | 2.00 | 34.0 | 6.40 | 95.2 | 11.40 | 76.7 | 12.00 |
| Colombia | 98.8 | 2.00 | 98.3 | 7.00 | 24.7 | 9.00 | 87.3 | 13.00 | 1.4 | 12.00 |
| Costa Rica | 100 | 0.34 | 100 | 4.50 | 0 | ? | 100 | 5.00 | 0 | ? |
| Ecuador | 89.5 | 1.00 | 88.2 | 3.80 | 32.9 | 1.40 | 86.7 | 11.50 | 51.0 | 2.00 |
| El Salvador | 100 | 1.30 | 96.0 | 8.00 | 31.4 | 2.50 | 100 | 19.00 | 42.5 | 14.70 |
| Guatemala | 100 | 3.00 | 79.8 | 7.00 | 37.2 | 8.00 | 100 | 19.00 | 75.0 | 14.00 |
| Honduras | 100 | 3.90 | 83.5 | 2.70 | 27.8 | 0.50 | 100 | 7.00 | 100 | 12.40 |
| Nicaragua | 100 | 0.04 | 53.1 | 4.00 | 53.1 | 4.40 | 88.4 | 16.00 | 58.4 | 2.40 |
| Paraguay | 100 | 0.70 | 92.9 | 13.00 | 0 | ? | 66.9 | 28.00 | 86.8 | 45.00 |
| Peru | 100 | 2.80 | 100 | 8.60 | 57.4 | 4.40 | 100 | 9.60 | 0 | 23.60g |
| Venezuela | 100 | 2.10 | 100 | 14.40 | 31.0 | 9.40 | 100 | 10.70 | 100 | 13.20 |
aCoverage of screening = (number of screened donors ÷ total number of donors) x 100.
bData as reported by the countries from 1993, except for Ecuador and Paraguay, which were for 1994.
cHBsAg only.
dCoverage.
ePrevalence.
fScreening not performed and prevalence not known.
gData from a survey of 2,237 samples.
Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.